课题基金 / 基金详情

Dendritic spine morphology and the Ubiquitin pathway

Dendritic spine morphology and the Ubiquitin pathway
树突棘形态和泛素通路
批准号:
7058068
负责人:
Xiaolu Ang Cambronne
金额:
$3.12万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-03-01 至 2009-02-28

项目摘要

项目成果

Xiaolu Ang Cambronne的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Dendritic spines in excitatory synapses can undergo dynamic actin-based morphological changes associated with synaptic plasticity. Recent examination into the molecular basis of this plasticity uncovered a role for SPAR, a RapGAP that targets to the PSD of dendritic spines. In turn, SPAR stability is regulated by serine/threonine kinase SNK. SNK phosphorylates SPAR, which promotes SPAR degradation through a proteasomal pathway. Nevertheless, the identity of the E3 Ub-ligases that target SPAR and how they are regulated is still unknown. Our investigation into the E3 Ub-ligases that target SPAR to regulate synaptic plasticity includes the following three major efforts: Aim 1 investigates roles for SCF Ub-ligases in SPAR degradation and the activation signals they recognize in the substrate; Aim 2 details a comprehensive approach to identify all E3 Ub-ligases that target SPAR; and Aim 3 examines how depletion of identified candidate E3 Ub-ligases affects dendritic spine morphology in primary hippocampal neurons. In addition to providing concrete evidence for the involvement of the Ub-pathway in the regulation of dendritic spine morphology, identification of the E3 Ub-ligases that mediate SPAR degradation is intrinsic to understanding the mechanism that may underlie a number of disorders associated with abnormal spine morphology and density, including general mental retardation, fragile-X syndrome, Down's syndrome, and epilepsy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mitochondrial NAD+ in Acute Myeloid Leukemias
  • 批准号:
    10655208
  • 项目类别:
  • 资助金额:
    $52.25万
  • 财政年份:
    2023
  • 负责人:
    Xiaolu Ang Cambronne
  • 依托单位:
Gatekeepers of Mitochondrial NAD+
  • 批准号:
    10301237
  • 项目类别:
  • 资助金额:
    $7.93万
  • 财政年份:
    2017
  • 负责人:
    Xiaolu Ang Cambronne
  • 依托单位:
Gatekeepers of Mitochondrial NAD+
Targets of microRNA-132 in adult neurogenesis
海外基金